TY - JOUR
T1 - Advances in bipolar disorder
T2 - Selected sessions from the 2011 International Conference on Bipolar Disorder
AU - Kupfer, David J.
AU - Angst, Jules
AU - Berk, Michael
AU - Dickerson, Faith
AU - Frangou, Sophia
AU - Frank, Ellen
AU - Goldstein, Benjamin I.
AU - Harvey, Allison
AU - Laghrissi-Thode, Fouzia
AU - Leboyer, Marion
AU - Ostacher, Michael J.
AU - Sibille, Etienne
AU - Strakowski, Stephen M.
AU - Suppes, Trisha
AU - Tohen, Mauricio
AU - Yolken, Robert H.
AU - Young, L. Trevor
AU - Zarate, Carlos A.
N1 - Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2011/12
Y1 - 2011/12
N2 - Recently, the 9th International Conference on Bipolar Disorder (ICBD) took place in Pittsburgh, PA, June 9-11, 2011. The conference focused on a number of important issues concerning the diagnosis of bipolar disorders across the life span, advances in neuroscience, treatment strategies for bipolar disorders, early intervention, and medical comorbidity. Several of these topics were discussed in four plenary sessions. This meeting report describes the major points of each of these sessions and included (1) strategies for moving biology forward; (2) bipolar disorder and the forthcoming new DSM-5 nomenclature; (3) management of bipolar disorders-both theory and intervention, with an emphasis on the medical comorbidities; and, (4) a review of several key task force reports commissioned by the International Society for Bipolar Disorder (ISBD).
AB - Recently, the 9th International Conference on Bipolar Disorder (ICBD) took place in Pittsburgh, PA, June 9-11, 2011. The conference focused on a number of important issues concerning the diagnosis of bipolar disorders across the life span, advances in neuroscience, treatment strategies for bipolar disorders, early intervention, and medical comorbidity. Several of these topics were discussed in four plenary sessions. This meeting report describes the major points of each of these sessions and included (1) strategies for moving biology forward; (2) bipolar disorder and the forthcoming new DSM-5 nomenclature; (3) management of bipolar disorders-both theory and intervention, with an emphasis on the medical comorbidities; and, (4) a review of several key task force reports commissioned by the International Society for Bipolar Disorder (ISBD).
KW - Bipolar disorders
KW - Diagnosis
KW - Medical comorbidity
KW - Neuroscience
UR - http://www.scopus.com/inward/record.url?scp=84155183380&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84155183380&partnerID=8YFLogxK
U2 - 10.1111/j.1749-6632.2011.06336.x
DO - 10.1111/j.1749-6632.2011.06336.x
M3 - Article
C2 - 22191553
AN - SCOPUS:84155183380
SN - 0077-8923
VL - 1242
SP - 1
EP - 25
JO - Annals of the New York Academy of Sciences
JF - Annals of the New York Academy of Sciences
IS - 1
ER -